These results highlight the critical role of growth factors and local stress events, such as oxidative stress and inflammatory stimuli [71], in the development of the endothelial dysfunction in CCM1- and CCM3-deficient cells, which may represent a therapeutic target. This evidence concerns the gene PDCD10 and endothelial dysfunction.